ICER has completed a brief review of the current evidence for stereotactic body radiation therapy (SBRT) for the treatment of low-risk prostate cancer.
ICER has completed a brief review of the current evidence for stereotactic body radiation therapy (SBRT) for the treatment of low-risk prostate cancer.